About CVRx, Inc.
CVRx is a commercial stage, public (NASDAQ: CVRX) medical devices company located in Minneapolis, Minnesota. The company has developed proprietary implantable technology for the treatment of high blood pressure and heart failure. Barostim™ triggers carotid baroreceptors - the body’s own natural blood flow regulation system - which signals the brain to regulate cardiovascular function.
Founded in 2001, CVRx is a leader in innovative technologies that address the unmet needs in cardiovascular diseases with safe and effective therapies. We have developed cutting edge technology that uses an implantable device to treat heart disease and heart failure, not only by reducing symptoms, but also increasing life expectancy. The Barostim Neo is the first and only neuromodulation device used to treat heart failure. This is a first-of its-kind technology has the ability to change lives across the globe and transform Physicians’ approach to heart failure.
CVRx is comprised of dedicated and talented industry leaders working together to make a mark within the medical device industry.
Our team works earnestly to fulfill the mission of serving the under-met need of heart failure patients and providing solutions that lead to longer, healthier lives.